TERF2IP and B-cell non-Hodgkin lymphoma: Families with germline mutations in TERF2IP are associated with early onset of CMM and a predisposition to a broad spectrum of primary cancers, including breast, lung, cervix, colon, bowel, ovary, and B-cell lymphoma, suggesting mutations in this gene may predispose to a wider range of cancers than just CMM [39].